NYU LANGONE HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1841-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nyulangone.org
Adapt and Incorporate dDPP Into Clinical Workflows
Withdrawn
- Conditions
- Physician-Patient RelationsNurse-Patient Relations
- Interventions
- Other: Digital Diabetes Prevention Program (dDPP)
- First Posted Date
- 2019-08-08
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT04049500
Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook
Phase 4
Withdrawn
- Conditions
- Cochlear ImplantCochlear Hearing Loss
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2020-05-29
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT04041596
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City Jails
Completed
- Conditions
- Hepatitis C
- Interventions
- Behavioral: Research transitional care coordination
- First Posted Date
- 2019-07-30
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 105
- Registration Number
- NCT04036760
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Safety and Feasibility of a Novel In--Bed Resistance Training Device in Elderly Inpatients
Not Applicable
Completed
- Conditions
- Old Age; Debility
- Interventions
- Other: In-Bed Resistance Training DeviceOther: Standard of Care
- First Posted Date
- 2019-07-19
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 11
- Registration Number
- NCT04026802
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Multimodal Analgesia With NSAID vs. Narcotics Alone After Shoulder Instability Surgery
Completed
- Conditions
- Shoulder Pain
- Interventions
- Other: Oxycodone/acetaminophen (Percocet) 5 mg/325Other: ibuprofen 600 mg
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2020-05-29
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 80
- Registration Number
- NCT04018768
- Locations
- 🇺🇸
New York University School of Medicine, New York, New York, United States
Use of Parent Connectors in First Episode Psychosis (FEP)
Not Applicable
Withdrawn
- Conditions
- First Episode Psychosis (FEP)
- Interventions
- Behavioral: CSC Usual CareBehavioral: PPN
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT04018521
Dual PD-1 and JAK2 Inhibition in Hematological Malignancies
Phase 2
Withdrawn
- Conditions
- CancerHematological Malignancy
- Interventions
- First Posted Date
- 2019-07-11
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT04016116
- Locations
- 🇺🇸
New York University School of Medicine, New York, New York, United States
Effects of a Three-Month Low Calorie Diet Weight Loss Intervention on Knee Replacement Outcomes
Not Applicable
Terminated
- Conditions
- Obesity
- Interventions
- Combination Product: LCD Intervention
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 13
- Registration Number
- NCT04015011
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
Active, not recruiting
- Conditions
- BRCA-Mutated Ovarian CarcinomaBRIP1 Gene MutationEPCAMMSH2 A636PRAD51C Gene MutationMLH1 Gene MutationMSH6 Gene MutationPMS2 Gene Mutation
- Interventions
- Other: CASCADE genetic screening
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 120
- Registration Number
- NCT04009148
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Device: Standard of Care MRIOther: Fluciclovine PET scan added to MRI
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 31
- Registration Number
- NCT04009083
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath